Suppr超能文献

多重聚合酶链反应在诊断癌症医院治疗患者尿液中分离的微生物中的可用性应用。

Usability application of multiplex polymerase chain reaction in the diagnosis of microorganisms isolated from urine of patients treated in cancer hospital.

机构信息

Department of Microbiology, Greater Poland Cancer Centre, Poznań, Poland.

出版信息

Radiol Oncol. 2013 Jul 30;47(3):296-303. doi: 10.2478/raon-2013-0044. eCollection 2013.

Abstract

BACKGROUND

THE OBJECTIVE OF THIS STUDY WAS: i) to compare the results of urine culture with polymerase chain reaction (PCR) -based detection of microorganisms using two commercially available kits, ii) to assess antimicrobial susceptibility of urine isolates from cancer patients to chosen antimicrobial drugs and, if necessary, to update the recommendation of empirical therapy.

MATERIALS AND METHODS

A one-year hospital-based prospective study has been conducted in Greater Poland Cancer Centre and Genetic Medicine Laboratory CBDNA Research Centre in 2011. Urine cultures and urine PCR assay from 72 patients were examined.

RESULTS

Urine cultures and urine PCR assay from 72 patients were examined. Urine samples were positive for 128 strains from which 95 (74%) were identical in both tests. The most frequently isolated bacteria in both culture and PCR assay were coliform organisms and Enterococcus spp. The Gram negative bacilli were most resistant to cotrimoxazol. 77.2% of these bacilli and 100% of E. faecalis and S. agalactiae were sensitive to amoxicillin-clavulanic acid. 4.7% of Gram positive cocci were resistant to nitrofurantoin.

CONCLUSIONS

The PCR method quickly finds the causative agent of urinary tract infection (UTI) and, therefore, it can help with making the choice of the proper antimicrobial therapy at an early stage. It appears to be a viable alternative to the recommendations made in general treatment guidelines, in cases where diversified sensitivity patterns of microorganisms have been found.

摘要

背景

本研究的目的是:i)比较两种市售试剂盒检测微生物的聚合酶链反应(PCR)与尿培养的结果,ii)评估癌症患者尿分离株对抗菌药物的药敏性,并在必要时更新经验性治疗的推荐。

材料与方法

2011 年,在大波兰癌症中心和遗传医学实验室 CBDNA 研究中心进行了为期一年的医院前瞻性研究。检查了 72 例患者的尿液培养和尿 PCR 检测。

结果

检查了 72 例患者的尿液培养和尿 PCR 检测。尿液样本中有 128 株阳性,其中 95 株(74%)在两种检测中均相同。两种检测中最常分离的细菌是大肠菌群和肠球菌属。革兰氏阴性杆菌对复方磺胺甲噁唑的耐药性最强。这些杆菌中 77.2%和粪肠球菌和无乳链球菌 100%对阿莫西林-克拉维酸敏感。4.7%的革兰氏阳性球菌对呋喃妥因耐药。

结论

PCR 方法可快速发现尿路感染(UTI)的病原体,因此可帮助在早期选择适当的抗菌治疗。在发现微生物的多样化药敏模式时,它似乎是对一般治疗指南推荐的可行替代方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/585b/3794886/84622276e7b1/rado-47-03-296f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验